Day One: Tuesday, June 4, 2024 - ET (Eastern Time, GMT-05:00)
Day One: Tuesday, June 4, 2024 - ET (Eastern Time, GMT-05:00)
- Aiko Laski - Senior Conference Producer, Informa Connect
- Stephan Ekmekjian - Co-Chair of Medtech Canada Compliance Committee, Health Care Compliance Officer, MedTech, Johnson & Johnson Canada
Hear from business leader panelists to gain an in-depth understanding of their pulse on the industry, including current business priorities, innovative business strategies and how to further business-compliance partnerships.
- Annie Bourgault - President, Integrated Pharma Services, Inc.
- Jonathan Soong - General Manager, Amicus Therapeutics Canada Inc.
Senior-level compliance and legal panelists dive into current and emerging challenges, forward-facing initiatives and how to augment and future-proof your compliance strategy to ensure efficient and compliant operations.
- Cinda Serianni - Associate General Counsel, Gilead Sciences Canada
- Suki Wiltman - Vice President, Global Business Ethics, Ipsen Biopharmaceuticals
- Nancy Tieu - Head of Ethics and Compliance, Takeda Canada
Leaders from across the business discuss navigating interdepartmental communication and collaboration challenges, strategies to optimize organization-wide operations and each leader’s future outlook on the bio/pharmaceutical/MedTech industry.
- Rosy Sasso - President, PBECC - Privacy, Business Ethics & Compliance Consulting
- Chrisoula Nikidis - Head, Ethics & Compliance Policy Shaping, Global Ethics and Compliance, Takeda
- Rowena Borenstein - Commercial Legal Lead, Established Markets, Astellas Pharma
- Shurjeel Choudhri - Senior Vice President & Head, Medical & Scientific Affairs, Bayer Inc
- Hélène Pineau - National Director - Patient Affairs and Advocacy, GSK
Hear from an HR executive panelist to explore the role of HR in various daily health care compliance activities, from conducting internal or externally-executed sensitive investigations
Explore the role the HR function can play in ensuring the enterprise-wide prioritization of DE&I elements in these health care compliance activities
- Stephan Ekmekjian - Co-Chair of Medtech Canada Compliance Committee, Health Care Compliance Officer, MedTech, Johnson & Johnson Canada
- Carrie Lipson, CHRP, Master of Human Resources Management - Human Resources Leader, Johnson & Johnson
Convene with industry peers during this facilitator-led Think Tank session dedicated to exploring the complexities and industry impact of the incorporation of AI in life sciences, key considerations for manufacturers in the utilization of AI and machine learning and resultant risk areas and what you need to know to effectively harness AI and reduce risk.
- Industry Analysis
- Use Case/Case Study
- Emerging Risks
- Best Practices and Guiding Principles for Compliance and Legal
Gain industry perspective on the role and importance of RWE and understand developments permitting the use of RWE in drug advertising.
- Tim Squire - Partner, Fasken
- Amy Moriarty - Senior Vice President and Managing Director, The AdPharm Inc.
- Andy Zylak - President, Mitsubishi Tanabe Pharma Canada
- Mark Vanderveken - Senior Associate, Fasken
- Audrey DeGuarde - Vice President, Global Transparency, RLDatix Life Sciences
Explore the role of the compliance officer in mergers and acquisitions
Navigate compliance challenges faced in mergers and acquisitions and discuss key considerations and effective strategies in ensuring a streamlined transition
- Eduardo Calazans - Health Care Compliance Officer, Johnson & Johnson MedTech
- Vanessa Grant - Partner, Norton Rose Fulbright Canada